In this issue:
Genomics for selecting metastatic breast cancer treatment
Acupuncture reduces aromatase inhibitor-related joint pain
Taxane type and chemotherapyinduced peripheral neuropathy in breast cancer
Adjuvant CIK + NK cell immunotherapy in post-mastectomy breast cancer
Switching aromatase inhibitor to fulvestrant, + palbociclib, in breast cancer with rising ESR1 mutation
SLNB for choosing chemotherapy in hormone receptor+, HER2– breast cancer with 1–3 positive nodes
Relapse and mortality after fertility preservation at breast cancer diagnosis
Adding everolimus to endocrine therapy in high-risk hormone receptor+, HER2– primary breast cancer
FES-PET for assessing oestrogen receptor status in metastatic breast cancer
Stereotactic RT and virus gene therapy in metastatic TNBC
Please login below to download this issue (PDF)